do not combine glp-1 receptor agonists with dpp-4 inhibitors guideline Can patients take and together? Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)
Description
The most common GLP-1 receptor agonists on the market include medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)

Available from: FDA approval for GLP-1 Agonist in patients with MASH

Regular physical activity can also contribute to a healthy lifestyle
Lassen, M

Its a natural hormone your body makes in the gut that helps control blood sugar, appetite and digestion
According to a report from WHO, in 2022, approximately 830 million people worldwide had diabetes, while 1 in 8 individuals globally were affected by obesity
